Merck & Co. Inc. logo

Merck & Co. Inc. (MRK)

$125.85

Merck & Co. Inc. (MRK) Share Price Forecast
Currently 31 wall-street analysts regularly analyze the financials of Merck & Co. Inc. on a frequent basis to provide recommendations along with target share price. 31 analysts offering 12-month price forecasts for Merck & Co. Inc. (MRK) have a share price target of $143.28. This median of share price forecast represents a 13.85% upside from the latest price of $125.85 as on 26.07.24.

Merck & Co. Inc. (MRK) Price vs Consensus Price Target

Price
Target Price
As per the chart shown above, analysts believe that the Merck & Co. Inc. (MRK) share price will touch around $143.28 in next 12-months.
Merck & Co. Inc. (MRK) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Merck & Co. Inc.'s share price and its median forecast price. As on 26.07.24, the difference is -10.73%

Merck & Co. Inc. (MRK): Difference between Current Price & Median Forecasted Price

Difference in Percentage terms
Merck & Co. Inc. (MRK) Share Price : Analyst Recommendation
Based on 31 analysts tracking and researching Merck & Co. Inc. (MRK) share have buy recommendation on an average.

3M Ago1M AgoCurrent
Buy
18
17
18
Outperform
9
10
9
Hold
6
5
4
Underperform
0
0
0
Sell
0
0
0
Merck & Co. Inc. (MRK) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

Moving Average
Price

200 Day Moving Average v/s Current Share Price

Moving Average
Price

FAQs

The latest share price target for Merck & Co. Inc. (MRK) is $143.28, offered by 31 analysts offering 12-month price forecasts.

Merck & Co. Inc. (MRK) has a maximum of 0.14 upside potential, based on 31 analysts offering 12-month price forecasts.

Based on 31 analysts tracking and researching Merck & Co. Inc. (MRK), 87.1% have a buy recommendation. Remaining 12.9% have either sell or hold recommendations.

The latest share price of Merck & Co. Inc. (MRK) is $125.85 as of 26/07/2024.

27 of total 31 analysts offering stock ratings for Merck & Co. Inc. MRK have recommended buy rating.